GV20 Trademark

Trademark Overview


On Thursday, August 26, 2021, a trademark application was filed for GV20 with the United States Patent and Trademark Office. The USPTO has given the GV20 trademark a serial number of 90903726. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Saturday, January 25, 2025. This trademark is owned by GV20 Therapeutics LLC. The GV20 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases

Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services;software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development
gv20

General Information


Serial Number90903726
Word MarkGV20
Filing DateThursday, August 26, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateSaturday, January 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements


Description of MarkThe mark consists of a stylized arrow, the outline of which consists of smaller blue squares from blue to light blue followed by the stylized text "GV20" in black font.
Goods and Servicespharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of genetic diseases
Pseudo MarkGV TWO ZERO; GV TWENTY
Indication of Colors claimedThe color(s) blue, light blue and black is/are claimed as a feature of the mark.
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services;software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGV20 Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02139

Party NameGV20 Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, August 30, 2021NEW APPLICATION ENTERED
Wednesday, October 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 14, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, June 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 1, 2022ASSIGNED TO EXAMINER
Monday, June 6, 2022NON-FINAL ACTION WRITTEN
Monday, June 6, 2022NON-FINAL ACTION E-MAILED
Wednesday, November 30, 2022ASSIGNED TO LIE
Tuesday, November 29, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 29, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, November 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 30, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, December 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 24, 2023SOU EXTENSION 1 FILED
Monday, January 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 29, 2024SOU EXTENSION 2 FILED
Monday, January 29, 2024SOU EXTENSION 2 GRANTED
Thursday, August 24, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 24, 2023SOU EXTENSION 1 GRANTED
Saturday, August 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024SOU EXTENSION 3 FILED
Wednesday, July 31, 2024SOU EXTENSION 3 GRANTED
Friday, January 24, 2025SOU TEAS EXTENSION RECEIVED
Saturday, January 25, 2025SOU EXTENSION 4 FILED
Saturday, January 25, 2025SOU EXTENSION 4 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED